Gossamer Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Gossamer Bio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.14 | $-0.15 | 6.67 % |
Jun 2024 | 2024-08-12 | $0.22 | $0.23 | -4.35 % |
Mar 2024 | 2024-05-07 | $-0.19 | $-0.18 | -5.56 % |
Dec 2023 | 2024-03-05 | $-0.21 | $-0.21 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $9.48M | $7.70M | 23.1 % |
Jun 2024 | 2024-08-12 | $95.84M | $114.29M | -16.1 % |
Gossamer Bio (GOSS) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.14, which beat the estimate of $-0.15.
The Actual Revenue was $9.5M, which beat the estimate of $7.7M.
Browse earnings estimates, EPS, and revenue on all stocks.